[Retracted] Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer

Table 1

General information [, ].

Group	Gender (male/female)	Average age (years)	Basal metabolism (kcal)	Body weight (kg)	Height (cm)
Comparison group (58)	36/22
Observation group (58)	37/21
	0.037	0.247	0.004	-0.030	0.009
	0.848	0.806	0.997	0.976	0.993